MeSH tree: E05.041.124.125
A study by Kuopio University Hospital and the University of Eastern Finland shows that sleep disturbances during pregnancy may be a significant risk factor for gestational diabetes mellitus (GDM).
May 19, 2026
0
1
A new study led by researchers at the University of Massachusetts Amherst suggests that even people with a high genetic risk for type 2 diabetes can substantially reduce their chances of developing the disease by adopting ...
May 19, 2026
0
12
New research presented at the European Congress on Obesity (ECO 2026) in Istanbul, Turkey, shows that rapid weight loss (RWL) is much more effective than gradual weight loss (GWL) in both achieving higher weight loss and ...
May 15, 2026
0
11
A weekly dose of semaglutide (2.4 mg) leads to a clinically significant reduction in body mass index (BMI) and related health outcomes in young adults with severe obesity who are treatment resistant following hospital-based ...
May 14, 2026
0
3
New research presented at the European Congress on Obesity in Istanbul, Turkey (12–15 May) shows that higher body mass index (BMI) is associated with more financial problems, loneliness, and stress. And these relationships ...
May 14, 2026
0
2
A recent study conducted at the University of Jyväskylä investigated the emotions evoked by physical activity and what motivates people across different weight groups to exercise. The study found that individuals with obesity ...
May 12, 2026
0
3
Predicting whether a healthy 45-year-old will struggle to climb stairs or walk a decade later has long been a challenge for geriatric medicine. Now, a study published in JMIR Aging, reveals that early mobility decline can ...
May 12, 2026
0
4
Analyses identified a high-risk subgroup of patients—described as the "lemon-on-sticks" phenotype—who had a high disease burden and poor outcomes, according to results presented today at Heart Failure 2026, the annual congress ...
May 11, 2026
0
4
New research presented at the European Congress on Obesity (ECO 2026, Istanbul, Turkey, 12–15 May) suggests that no matter where people live, eating out instead of preparing meals at home is linked to weight gain and obesity.
May 10, 2026
0
9
A new analysis of the STEP trials carried out by semaglutide manufacturer Novo Nordisk has analyzed various trials to show the safety and efficacy of the obesity drug semaglutide in older adults (over 65 years), and found ...
May 10, 2026
0
6
